If this message is not displayed correctly, click here.
FOR KIDNEY & BLOOD
PRESSURE RELATED
DISORDERS
 |
 |
 |
An official publication of
|
|
NDT-Educational@ENP Newsletter
Issue 8 - June 2019
|
|
EDITOR IN CHIEF: Davide Bolignano
EDITORIAL BOARD: click here for the complete list
NEWSLETTER DESIGN: Francesca Trebelli
|
|
Summary Reports from 55th ERA-EDTA Congress
Do we still need calcineurin inhibitors in 2018?
Presented by Daniel Abramowicz
Calcineurin inhibitors (CNIs)-based therapy is still a cornerstone of immunosuppressive regimens in kidney transplantation. Nevertheless, their use did not improve long-term graft survival. The possible causes for this may be nephrotoxicity, underimmunesuppression or both. In recent years the problem of inadequate suppression of anti-human leukocyte antigen antibodies by the CNIs has emerged calling for new, safer drugs.
|
|
Congress Presentation
This talk has been presented by Daniel Abramowicz during the 55th ERA-EDTA Congress in Copenhagen, Denmark.
|
|
|
|
References
Read this selection of articles about the two summary report fields.
|
|
New Editorial Board Member!
Nuria Montero Perez, Spain
|
|
New ERA-EDTA Dialogues!
Alternative techniques in the treatment of resistant hypertension
by Evangelia Ntounousi
Unexpected findings in a renal transplant candidate
by Ana Carina Ferreira
|
|
Last weeks to comment these ERA-EDTA Dialogues!
Predicting outcomes in ANCA-associated GN: your “real-life” experience
by Francesco Pesce
Drug adherence in CKD-MBD: Which Binder?
by Björn Meijers
Vascular access for hemodialysis in the elderly (75+)
by Kusztal Mariusz
|
|
FOLLOW US
|
|
|
 |
 |
 |
|
|
The ERA-EDTA collects and processes personal information to provide you with details regarding the Association and its activities. The information is used for accounting and commercial purposes by ERA-EDTA and/or Euromeetings s.r.l. in compliance with the EU General Data Protection Regulation (2016/679).